Equitable Trust Co
- SEC CIK
- 0000033250
- Latest filing
- Jul 23, 2026
ELAN holding history
Elanco Animal Health Inc in every 13F filed by Equitable Trust Co, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ELAN overviewAll 13F holders of ELANFull Q2 2026 holdings
- Shares (Q2 2026)
- 280,725
- Value
- $6.91M
- % of portfolio
- 0.3%
- Quarters held
- 18
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 280,725 | $6.91M | 0.3% | +9,252+3.4% | Added | Holders |
| Q1 2026 | 271,473 | $6.50M | 0.3% | +28,520+11.7% | Added | Holders |
| Q4 2025 | 242,953 | $5.50M | 0.2% | +2,968+1.2% | Added | Holders |
| Q3 2025 | 239,985 | $4.83M | 0.2% | −8,123−3.3% | Reduced | Holders |
| Q2 2025 | 248,108 | $3.54M | 0.2% | +98,172+65.5% | Added | Holders |
| Q1 2025 | 149,936 | $1.57M | 0.1% | +24,129+19.2% | Added | Holders |
| Q4 2024 | 125,807 | $1.52M | 0.1% | +125,807 | New | Holders |
| Q1 2024 | 0 | $0 | 0.0% | −10,297−100.0% | Sold out | Holders |
| Q4 2023 | 10,297 | $153.4K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2023 | 10,297 | $115.7K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 10,297 | $103.6K | <0.1% | +10,297 | New | Holders |
| Q1 2023 | 0 | $0 | 0.0% | −10,655−100.0% | Sold out | Holders |
| Q4 2022 | 10,655 | $130.2K | <0.1% | −11,224−51.3% | Reduced | Holders |
| Q3 2022 | 21,879 | $271.0K | <0.1% | +727+3.4% | Added | Holders |
| Q2 2022 | 21,152 | $415.0K | <0.1% | −2,150−9.2% | Reduced | Holders |
| Q1 2022 | 23,302 | $608.0K | <0.1% | +3,876+20.0% | Added | Holders |
| Q4 2021 | 19,426 | $551.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2021 | 19,426 | $619.0K | <0.1% | −2,849−12.8% | Reduced | Holders |
| Q2 2021 | 22,275 | $773.0K | <0.1% | −3,313−12.9% | Reduced | Holders |
| Q1 2021 | 25,588 | $754.0K | 0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.